Wes Wheeler Appointed as CEO by Marken's Board of Directors

LONDON, May 25, 2011 -

The Marken Board of Directors is pleased to announce the appointment of
Wesley P. Wheeler, MBA as Chief Executive Officer. Mr. Wheeler succeeds
Gerard Barba, who will remain the Chairman of the Marken Board of Directors.

Marken's Board and executive management team have sought to add an
executive such as Mr. Wheeler for his depth of experience in the life science
industry as well as a strong background in logistics to further strengthen
market leadership and maintain Marken's solid growth path.

Prior to joining Marken, Wes held the title of President and CEO of
Patheon Inc., a top contract manufacturing services company. Wes was also a
former President of Valeant Pharmaceuticals International, and has previously
held senior executive roles of increasing responsibility in manufacturing,
marketing and engineering at GlaxoSmithKline, plc. Preceding his 22 year
career in pharmaceuticals, Mr. Wheeler had a successful 12 year career at
ExxonMobil. He holds a bachelor's degree in Mechanical Engineering and a
Masters of Business Administration.

"As the nature of biopharmaceutical R&D changes, well controlled clinical
supply chains will be a significant factor in the success of key life science
companies and the industries that support them. The Board and I feel that Wes
can bring his experience from the drug manufacturing, biotechnology and
traditional pharmaceutical industries to augment an already strong management
team and continue Marken's growth," said Gerard Barba, Marken's Chairman.

Mr. Khawar Mann, managing partner, APAX LLP., said: "We are delighted
that Wes has agreed to join us at Marken. His operations background and
successful track record in the pharmaceutical industry will give us the tools
we need to continue building Marken's portfolio of services and geographies,
and thus realize our greatest potential as a leading logistics services
provider."

About Marken

Founded in 1980, Marken is focused on supporting the logistics of life
Science companies. They manage the global collection, transportation, storage
and distribution of specimens and clinical trial supplies. Additionally
through their depot network, Marken supports regional storage and
distribution of life science materials. Marken's team members and network of
facilities bridge the distance between patients and the essential resources
of life science companies.

www.marken.com

Elan Josielewski, Elan.Josielewski at marken.com, +1-347-855-3526, www.marken.com